ARCHIVES

ODAC Recommends Ethyol, DaunoXome For FDA Approval

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Information Officer Plays Key Role In Cancer Program

February 8, 1980

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

February 15, 2002